Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,450
Out of 5,090 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $150.46 | +16.31% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $53.84 | +11.44% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $16.26 | +330.50% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $113.19 | +1.60% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $75.03 | +6.62% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $0.73 | +10,173.97% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $150.46
Upside: +16.31%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $53.84
Upside: +11.44%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $16.26
Upside: +330.50%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $113.19
Upside: +1.60%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $75.03
Upside: +6.62%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $0.73
Upside: +10,173.97%